Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis.
Huang KC, Hsu SP, Yang CC, Ou-Yang P, Lee KT, Morisawa S, Otsubo K, Chien CT. · Nephrology Dialysis Transplantation · 2010
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this human study, supporting further research into its potential for dialysis.
Molecular hydrogen dialysis study 2010: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This uncontrolled human study examined Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis. The abstract describes Human participants; reported duration 1 year. Antioxidant electrolysed-reduced water (ERW) was used as the dialysate in ESRD patients undergoing chronic HD to test for improved oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them)-related T-cell apoptosis (programmed cell death), alterations….
Publication: Huang KC, Hsu SP, Yang CC, Ou-Yang P, Lee KT, Morisawa S, Otsubo K, Chien CT., Nephrology Dialysis Transplantation, 2010.
What the researchers studied
Antioxidant electrolysed-reduced water (ERW) was used as the dialysate in ESRD patients undergoing chronic HD to test for improved oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them)-related T-cell apoptosis (programmed cell death), alterations…
What effects did molecular hydrogen have?
Observed hydrogen effects: Antioxidant electrolysed-reduced water (ERW) was used as the dialysate in ESRD patients undergoing chronic HD to test for improved oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them)-related T-cell apoptosis (programmed cell death), alterations… BackgroundT-cell damage by increased oxidative stress in end-stage renal disease (ESRD) patients undergoing chronic haemodialysis (HD) led to the increased T-cell apoptosis and the alteration of surface markers and Th1/Th2 ratio in CD4(+) T lymphocytes.
Why these findings matter
The reported benefit supports the therapeutic potential of molecular hydrogen for dialysis under the conditions tested. Because people were studied, this is directly relevant to clinical research, but larger independent trials are still needed before hydrogen can be considered an established treatment.
How strong is this evidence?
This is direct human evidence with a comparison group.
Technical study details
- Publication type: Uncontrolled human study
- Evidence type: Human clinical evidence
- Research model or population: Human participants
- Hydrogen method: Other or not reported
- Treatment duration: 1 year
Limitations and safety
Important limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.